1.Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis.
Hana PARK ; Sung Hoon KIM ; Yoo Mi CHO ; Hyo Jin IHM ; Young Sang OH ; Seung Hwa HONG ; Hee Dong CHAE ; Chung Hoon KIM ; Byung Moon KANG
Obstetrics & Gynecology Science 2016;59(2):123-129
OBJECTIVE: Nuclear factor kappa-B (NF-κB) is a critical proinflammatory regulator that has been suggested to play a pivotal role in the pathogenesis and pathophysiology of endometriosis. In the present study, we aimed to evaluate whether the expression of NF-κB p65 subunit is increased in the eutopic endometrium and/or in the adenomyosis nodule of women with adenomyosis. METHODS: Thirty-three women with histologically confirmed adenomyosis after laparoscopic or transabdominal hysterectomy were recruited. Women with carcinoma in situ of uterine cervix without evidence of adenomyosis or endometriosis (n=32) served as controls. Formalin-fixed, paraffin-embedded archival tissues were sectioned and immunostained utilizing a monoclonal anti-human NF-κB p65 subunit antibody, and the immunoreactivity of NF-κB p65 subunit was compared between women with and without adenomyosis. RESULTS: The immunoreactivities of both the nuclear and the cytoplasmic NF-κB p65 subunit were significantly increased in the stromal cells in the eutopic endometrium as well as in the adenomyosis nodule of women with adenomyosis compared with controls, respectively. The nuclear expression of NF-κB p65 subunit was significantly higher in the glandular cells in the eutopic endometrium as well as the adenomyosis nodule of women with adenomyosis compared with controls, respectively. CONCLUSION: The expression of NF-κB p65 is increased in the eutopic endometrium and adenomyosis nodule of women with adenomyosis, which strongly suggest that NF-κB plays a critical role in the pathogenesis and/or pathophysiology of adenomyosis.
Adenomyosis*
;
Carcinoma in Situ
;
Cervix Uteri
;
Cytoplasm
;
Endometriosis
;
Endometrium
;
Female
;
Humans
;
Hysterectomy
;
NF-kappa B
;
Stromal Cells
2.Prognostic factors in neuroendocrine cervical carcinoma.
Da Yong LEE ; Chul CHONG ; Maria LEE ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG ; Sang Yoon PARK
Obstetrics & Gynecology Science 2016;59(2):116-122
OBJECTIVE: To evaluate the clinical and pathologic factors associated with survival in patients with neuroendocrine cervical carcinoma (NECC). METHODS: The records of 61 patients with NECC diagnosed between 2000 and 2014 at Seoul National University Hospital and the National Cancer Center were retrospectively reviewed. Kaplan-Meier and Cox regression methods were used for analyses. RESULTS: Of the 61 patients, 67.2% were diagnosed at early stage (I to IIA) with a median age of 49 years. Of those, 78% underwent surgery and 75.6% received postoperative adjuvant treatment. For patients diagnosed at advanced stage, 60.0% received chemotherapy only and 25.0% received concurrent chemoradiation therapy. In the univariate analysis, advanced stage (77 vs. 40 months, P=0.013), tumor size ≥2 cm (133 vs. 47 months, P=0.002) and mixed tumor (101 vs. 34 months, P=0.004) were shown to be poor prognostic factors. In the multivariate analysis, tumor stage, tumor size and tumor homology were shown to be independent prognostic factors for overall survival. Of the total, 39.3% of the patients experienced recurrence, and 54.1% of the patients had metastasis. Of the patients diagnosed at early stage, 51.2% experienced recurrence. CONCLUSION: Tumor stage, tumor size and tumor homology were found to be independent prognostic factors in patients with NECC. Even in patients diagnosed at early stage, recurrence and distant metastasis were frequently observed.
Carcinoma, Neuroendocrine
;
Carcinoma, Small Cell
;
Drug Therapy
;
Humans
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
;
Seoul
3.Folic acid alone or multivitamin containing folic acid intake during pregnancy and the risk of gestational hypertension and preeclampsia through meta-analyses.
Sang Min SHIM ; Yeo Ul YUN ; Yun Sook KIM
Obstetrics & Gynecology Science 2016;59(2):110-115
OBJECTIVE: The objective of this study was to assess the effect of folic acid and multivitamin use during pregnancy on the risk of developing of hypertensive disorder of pregnancy. METHODS: Two reviewers independently determined all prospective cohort study, retrospective cohort study, large population based cohort study, retrospective secondary analysis, and double blinded, placebo-controlled, randomized clinical trial published using PubMed Medline database, KERIS (Korea Education and Research Information Service), Scopus, and the Cochrane Central Register of controlled trials comparing before conception throughout pregnancy intake oral multivitamin containing folic acid or folic acid alone. Meta-analyses were estimated with odds ratios and 95% confidence intervals (CIs) using random effect analysis according to heterogeneity of studies. RESULTS: Data from six effect sizes from six studies involving 201,661 patients were enrolled. These meta-analyses showed multivitamin containing folic acid or folic acid alone was not significantly effective in reducing gestational hypertension or preeclampsia incidence (odds ratio, 0.91; 95% CI, 0.81 to 1.03) than the placebo. And the difference of effective sizes of preeclampsia and gestational hypertension according to two dependent variables, multivitamin and folic acid were not significant, respectively (point estimate, 0.66; 95% CI, 0.46 to 0.96). CONCLUSION: These meta-analyses demonstrate multivitamin containing folic acid or folic acid alone was not significantly effective in reducing gestational hypertension or preeclampsia incidence.
Cohort Studies
;
Education
;
Female
;
Fertilization
;
Folic Acid*
;
Humans
;
Hypertension, Pregnancy-Induced*
;
Incidence
;
Odds Ratio
;
Population Characteristics
;
Pre-Eclampsia*
;
Pregnancy*
;
Prospective Studies
;
Retrospective Studies
4.Safety of cesarean delivery through placental incision in patients with anterior placenta previa.
Deok Ho HONG ; Eugene KIM ; Kyu Sang KYEONG ; Seung Hwa HONG ; Eun Hwan JEONG
Obstetrics & Gynecology Science 2016;59(2):103-109
OBJECTIVE: To demonstrate the safety of fetal delivery through placental incision in a placenta previa pregnancy. METHODS: We examined the medical records of 80 women with singleton pregnancy diagnosed with placenta previa who underwent cesarean section between May 2010 and May 2015 at the Department of Obstetrics and Gynecology, Chungbuk National University Hospital. Among the women with placenta previa, those who did not have the placenta in the uterine incision site gave birth via conventional uterine incision, while those with anterior placenta previa or had placenta attached to the uterine incision site gave birth via uterine incision plus placental incision. We compared the postoperative hemoglobin level and duration of hospital stay for the mother and newborn of the two groups. RESULTS: There was no difference between the placental incision group and non-incision group in terms of preoperative and postoperative hemoglobin change, the amount of blood transfusions required by the mother, newborns with 1-min or 5-min Apgar scores below 7 points or showing signs of acidosis on umbilical cord blood gas analysis result of pH below 7.20. Moreover, neonatal hemoglobin levels did not differ between the two groups. CONCLUSION: Fetal delivery through placental incision during cesarean section for placenta previa pregnancy does not negatively influence the prognosis of the mother or the newborn, and therefore, is considered a safe surgical technique.
Acidosis
;
Anemia, Neonatal
;
Blood Transfusion
;
Cesarean Section
;
Chungcheongbuk-do
;
Female
;
Fetal Blood
;
Gynecology
;
Humans
;
Hydrogen-Ion Concentration
;
Infant, Newborn
;
Length of Stay
;
Medical Records
;
Mothers
;
Obstetrics
;
Parturition
;
Placenta Previa*
;
Placenta*
;
Pregnancy
;
Prognosis
5.Preoperative and postoperative serum C-reactive protein levels to predict the outcome of ultrasound-indicated cerclage.
Hyun Jeong YIM ; Ji Eun SONG ; Ji Eun KIM ; Ga Hyun SON ; Keun Young LEE
Obstetrics & Gynecology Science 2016;59(2):97-102
OBJECTIVE: To assess the role of preoperative and postoperative serum C-reactive protein (CRP) level on the prediction of pregnancy outcomes following ultrasound-indicated cerclage (UIC). METHODS: We retrospectively reviewed the medical records 44 women who underwent UIC between January 2011 and December 2011. UIC was performed between 14 and 24 weeks of gestation in women with short cervix. We divided UIC patients into two groups according to the gestational age at delivery (34 weeks) and compared the two groups. Group A was defined as patients who delivered ≥34 weeks of gestation, and group B as patients delivered <34 weeks. Correlation and receiver-operating characteristic curves were also analyzed for the prediction of preterm birth after UIC. RESULTS: Thirty women delivered ≥34 weeks (group A) and 14 women delivered <34 weeks (group B). Pre- and post-cerclage CRP were significantly lower in group A (pre-cerclage CRP, 1.1±1.0 vs. 11.4±6.2 mg/dL, P<0.001; post-cerclage CRP, 0.6±0.5 vs. 7.4±7.2 mg/dL, P<0.001). The mean gestational age at delivery in group A was 37.7±1.8 weeks and that in group B was 26.9±4.3 weeks (P<0.001). There were significant negative correlations between pre- and post-cerclage CRP and latency from UIC to delivery (r=-0.82, P<0.001; r=-0.70, P<0.001, respectively). CONCLUSION: Both pre- and post-cerclage CRP were useful in predicting the preterm birth following UIC.
C-Reactive Protein*
;
Cervix Uteri
;
Female
;
Gestational Age
;
Humans
;
Medical Records
;
Pregnancy
;
Pregnancy Outcome
;
Premature Birth
;
Retrospective Studies
6.Simple mathematical formulae for estimation of median values of fetal biometry at each gestational age.
Hwa Young CHOI ; Jeong Ha KIM ; Jee Yoon PARK ; Eun Young JUNG ; Jae Hong NO ; Kyung Joon OH ; Joon Seok HONG
Obstetrics & Gynecology Science 2016;59(2):91-96
OBJECTIVE: The aim of this study was to propose simple mathematical formulae to estimate median values of fetal biometry including biparietal diameter (BPD), abdominal circumference (AC) and femur length (FL) at each gestational age (GA) easily without looking up the previously established reference values. METHODS: Simple mathematical formulae to estimate median values of fetal biometric values at each gestational week were inferred. To validate these formulae, three different linear equations were derived from previously reported reference values of median BPD, AC and FL using regression analysis at each gestational week. Finally, calculated data through the inferred formula were compared to retrospectively collected data (observed data). RESULTS: The equation revealing the relationship between BPD and GA was: median BPD (cm)=GA (wk)/4. Using this simple mathematical formula, the absolute percentage error between observed data and calculated data ranged from 0.12% to 7.50%. The equation between AC and GA was: median AC (cm)=GA (wk)-5. Through this formula, the absolute percentage error was analyzed same as above and it ranged from 0.30% to 4.76%. Lastly the derived formula between FL and GA was: median FL (cm)=GA (wk)/5 and the absolute percentage error ranged from 4.52% to 16.75%. CONCLUSION: The three simple formulae suggested in our study showed a significantly easy way to estimate the median values of fetal biometry at each gestational week with good reliability.
Biometry*
;
Femur
;
Gestational Age*
;
Reference Values
;
Retrospective Studies
;
Ultrasonography
7.External cephalic version experiences in Korea.
Mi Young KIM ; Min Young PARK ; Gwang Jun KIM
Obstetrics & Gynecology Science 2016;59(2):85-90
OBJECTIVE: The aim of this study was to evaluate obstetric outcomes of external cephalic version (ECV) performed at or near term. METHODS: Single pregnant woman with breech presentation at or near term (n=145), who experienced ECV by one obstetrician from November 2009 to July 2014 in our institution were included in the study. Maternal baseline characteristic and fetal ultrasonographic variables were checked before the procedure. After ECV, the delivery outcomes of the women were gathered. Variables affecting the success or failure of ECV were evaluated. RESULTS: Success rate of ECV was 71.0% (n=103). Four variables (parity, amniotic fluid index, fetal spine position and rotational direction) were observed to be in correlation with success or failure of ECV. In contactable 83 individuals experienced successful ECV, cesarean delivery rates were 18.1%, 28.9%, and 5.3% in total, nulliparas, and multiparas, respectively. CONCLUSION: Based on the results, ECV is proposed to be safe for both mother and her fetus. In addition, it is a valuable procedure that increases probability of vaginal delivery for women with breech presentation.
Amniotic Fluid
;
Breech Presentation
;
Female
;
Fetus
;
Humans
;
Korea*
;
Mothers
;
Pregnancy
;
Pregnant Women
;
Spine
;
Version, Fetal*
8.Fetal heart rate monitoring: from Doppler to computerized analysis.
Obstetrics & Gynecology Science 2016;59(2):79-84
The monitoring of fetal heart rate (FHR) status is an important method to check well-being of the baby during labor. Since the electronic FHR monitoring was introduced 40 years ago, it has been expected to be an innovative screening test to detect fetuses who are becoming hypoxic and who may benefit from cesarean delivery or operative vaginal delivery. However, several randomized controlled trials have failed to prove that electronic FHR monitoring had any benefit of reducing the perinatal mortality and morbidity. Also it is now clear that the FHR monitoring had high intra- and interobserver disagreements and increased the rate of cesarean delivery. Despite such limitations, the FHR monitoring is still one of the most important obstetric procedures in clinical practice, and the cardiotocogram is the most-used equipment. To supplement cardiotocogram, new methods of computerized FHR analysis and electrocardiogram have been developed, and several clinical researches have been currently performed. Computerized equipment makes us to analyze beat-to-beat variability and short term heart rate patterns. Furthermore, researches about multiparameters of FHR variability will be ongoing.
Cardiotocography
;
Electrocardiography
;
Female
;
Fetal Heart*
;
Fetus
;
Heart Rate
;
Heart Rate, Fetal*
;
Mass Screening
;
Perinatal Mortality
;
Pregnancy
9.A Case of Adenocarcinoma arising from a Mature Cystic Teratoma of the Ovary.
Leek Bum CHON ; Chan LEE ; Yong Hun CHEE ; Kye Won KWON ; Hee Jung AHN ; Jung Soo KIM
Korean Journal of Obstetrics and Gynecology 1997;40(10):2362-2366
Malignant transformation of mature cystic teratoma is a rare complication. Most com-mon malignant transformation of mature cystic teratoma is squamous cell carcinoma, which represents about 75 to 80% followed by adenocarcinoma in 6 to 7%. It is generally consi-dered that prognosis is extremely poor in case of adenocarcinoma associated with cystic te-ratoma. In this paper, we describe an adenocarcinoma arising from a mature cystic teratoma of left ovary in 47 year old woman. Left ovary was measured 18x15x7cm, 1,295gm in size. Uterus and right ovary were normal appearance. Left ovarian cyst was adhered to omentum and peritoneum. But neither rupture of cyst nor ascites were found at laparotomy. A brief review of concerned literatures was presented.
Adenocarcinoma*
;
Ascites
;
Carcinoma, Squamous Cell
;
Female
;
Humans
;
Laparotomy
;
Middle Aged
;
Omentum
;
Ovarian Cysts
;
Ovary*
;
Peritoneum
;
Prognosis
;
Rupture
;
Teratoma*
;
Uterus
10.Squamous Cell Carcinoma arising in Cystic Teratoma of the Ovary.
Dae Hyun JUNG ; Chong Ho KIM ; Tae Wook YOO ; Young Jeong NA ; Kyung Tai KIM ; Yeun Young HWANG ; Seung Sam PAIK ; Moon Hyang PARK ; Dae Woon KIM
Korean Journal of Obstetrics and Gynecology 1997;40(10):2355-2361
The cystic teratoma is the most common germ cell tumors in reproductive age women. The malignant change of cystic teratoma is rare, about 1~2%, and mostly change to squ-amous cell carcinoma. We experienced 4 cases of squamous cell carcinoma arising in cystic teratoma and re- port our cases with a brief review of the literature.
Carcinoma, Squamous Cell*
;
Female
;
Humans
;
Neoplasms, Germ Cell and Embryonal
;
Ovary*
;
Teratoma*